Peptide II (Buthussindicus venom reduced) (9CI)(125383-78-0)
- Name: Peptide II (Buthussindicus venom reduced) (9CI)
- Synonyms:L-Valine,L-valylglycyl-L-cysteinyl-L-a-glutamyl-L-a-glutamyl-L-a-aspartyl-L-prolyl-L-methionyl-L-histidyl-L-cysteinyl-L-lysylglycyl-L-lysyl-L-glutaminyl-L-alanyl-L-lysyl-L-prolyl-L-threonyl-L-cysteinyl-L-cysteinyl-L-asparaginylglycyl-L-valyl-L-cysteinyl-L-asparaginyl-L-cysteinyl-L-asparaginyl-
- Molecular Formula:C116H191 N37 O40 S7
- Molecular Weight:
- CAS Registry Number:125383-78-0
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 16545-23-6/5,4''-DIHYDROXY-6,7,8-TRIMETHOXYFLAVONE
- 59687-74-0/diphenyl 2-(diethylsulfamoyl)benzene-1,4-dicarboxylate
- 79388-04-8/1,6-diamino-2-oxo-4-phenyl-1,2-dihydropyridine-3,5-dicarbonitrile
- 5337-16-6/N-[[(diisopropylamino)-(4-nitrophenyl)phosphoryl]oxy-(4-nitrophenyl)phosphoryl]-N-isopropyl-propan-2-amine
- 26984-08-7/PETUNIDIN
- 32848-17-2/naphthalen-1-yl 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate
- 139556-89-1/tert-Tridecanoic acid,ethyl ester (9CI)
- 6410-70-4/9-(phenylsulfonyl)hexahydro-5,6-epimino-4,7-methano-2-benzofuran-1,3-dione
- 23639-49-8/4,7-Ethanobenzoxazole,2,3-dihydro-
- 42902-52-3/3-m-toluidinopropane-1,2-diol
- 66230-26-0/Benzothiazolium,2-[4-[4-(dimethylamino)phenyl]-1,3-butadien-1-yl]-3-ethyl-, iodide (1:1)
- 25458-12-2/(6Z)-6-{[(2-hydroxy-1,1-dimethylethyl)amino]methylidene}-2-nitrocyclohexa-2,4-dien-1-one
- 145403-25-4/Stigmast-8(14)-en-3-one,4-methylene-, (5a,24S)-(9CI)
- 5585-11-5/Phosphonodithioic acid,methyl-, O-ethyl ester, S-ester with tetrahydro-3-mercapto-2H-pyran-2-one (8CI)
- 112649-21-5/Garcinone E
- 169063-72-3/Ergosta-7,24-dien-6-one,2,3,14,20,22,26-hexahydroxy-, (2b,3b,5b,22R)- (9CI)
- 6372-17-4/(5Z)-5-{4-[2-(2,4-dimethylphenoxy)ethoxy]benzylidene}-3-methyl-2-thioxo-1,3-thiazolidin-4-one
- 42782-96-7/methyl (5Z,11alpha,13E)-11,15-dihydroxy-16,16-dimethyl-9-oxoprosta-5,13-dien-1-oate
- 73018-78-7/Chromate(3-),[5-amino-4-(hydroxy-kO)-3-[2-[2-(hydroxy-kO)-5-nitrophenyl]diazenyl-kN1]-2,7-naphthalenedisulfonato(4-)][2-[2-[4,5-dihydro-3-methyl-5-(oxo-kO)-1-phenyl-1H-pyrazol-4-yl]diazenyl-kN1]benzoato(2-)-kO]-, hydrogen (1:3)
- 125383-78-0/Peptide II (Buthussindicus venom reduced) (9CI)
- 73129-35-8/1-(6-fluoro-10,11-dihydrodibenzo[b,f]thiepin-10-yl)-4-methylpiperazine dimethanesulfonate
- 41988-33-4/((7-(2-(1-(m,p-Dimethoxybenzyl)-3,4-dihydro-6,7-dimethoxyisoquinolin-2(1H)-yl)-2-oxoethoxy)-4-oxo-2-phenyl-4H-1-benzopyran-5-yl)oxy)acetic acid, compound with 2,2-iminodiethanol (1:1)
- 6601-05-4/5-[2-(diethylamino)ethyl]-1,3,5-triazinane-2-thione
- 114703-72-9/1-methyl-5-phenyl-1,4,5,6-tetrahydropyrimidine hydrochloride
- 61384-24-5/bis(1-hydroxy-2,2,6,6-tetramethylpiperidin-4-yl) (2-phenylethyl)phosphoramidate
- 70152-61-3/Cyclohexanecarboxylicacid, strontium salt (2:1)
- 17299-26-2/phenyl (Z)-2-phenylethenesulfonate
- 6268-64-0/2-bromo-1-ethyl-1,2-dihydropyridine
- 185446-70-2/L-Isoleucine,N-methyl-N-(1-oxobutyl)-L-valyl-L-valyl-N,O-dimethyl-L-tyrosyl-N-methyl-,methyl ester (9CI)
- 27077-16-3/N,N-bis(2-chloroethyl)-2-phenoxyaniline